Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 6:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction
Interventions: 36.25 Gy IMRT, 51.6 Gy IMRT; Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 32
States / cities: Birmingham, Alabama • Peoria, Arizona • Phoenix, Arizona + 25 more

Conditions: Transposition of Great Vessels, Congenital Heart Disease
Interventions: N-acetylcysteine, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: Up to 3 Months
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Alcohol Dependence
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Aging
Interventions: repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Endometriosis, Pelvic Pain
Interventions: Relugolix CT; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Myofascial Dysfunction
Interventions: Imaging; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Erectile Dysfunction
Interventions: Nebivolol, Sugar Pill; Drug
Lead sponsor: Martin M. Miner, MD; Other
Eligibility: 25 Years to 65 Years · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: Providence, Rhode Island

Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 89 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Ischemic Left Ventricular Dysfunction, Myocardial Infarction
Interventions: Allogeneic hMSCs; Biological
Lead sponsor: Joshua M Hare; Other
Eligibility: 21 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Preeclampsia Severe or Mild, Cardiac Complication
Interventions: Echocardiogram, Blood draw; Diagnostic Test
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Alzheimer's Disease (Incl Subtypes), Cognitive Impairment
Interventions: Enhanced psycho-education about dementia and caregiving; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 21 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Mechanical Ventilation, Autonomic Nervous System Diseases
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cerebrovascular Disease, Stroke
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 21 Years and older
Enrollment: 840 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2008
U.S. locations: 3
States / cities: Bethesda, Maryland • Silver Spring, Maryland

Conditions: Dyspareunia
Interventions: Prasterone; Drug
Lead sponsor: San Diego Sexual Medicine; Other
Eligibility: 21 Years to 80 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Alzheimer's Disease, Dementia, Memory Impairment, Cognitive Impairment
Interventions: RDAD; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 65 Years and older
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Solid Neoplasm, Unresectable Solid Neoplasm
Interventions: Trametinib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 8
States / cities: Sacramento, California • Tampa, Florida • Chicago, Illinois + 5 more

Conditions: Traumatic Brain Injury, Cognitive Impairment
Interventions: Rivastigmine Transdermal Patch; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years to 65 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 8
States / cities: San Diego, California • Miami, Florida • Tampa, Florida + 5 more

Conditions: Mild Cognitive Impairment, Amnestic Mild Cognitive Impairment - aMCI
Interventions: NeuroElectric StarStim, Sham Treatment; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 55 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Healthy Subjects, Schizophrenia, Parkinson Disease
Interventions: Oxygen-15 Water; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 1,039 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1993
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Non Alcoholic Fatty Liver Disease
Interventions: Weight loss, Exercise; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 60 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Cognitive Dysfunction, Mild Cognitive Impairment
Interventions: Group psychotherapy delivered via video telehealth; Behavioral
Lead sponsor: Tuscaloosa Research & Education Advancement Corporation; Other
Eligibility: 60 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Tuscaloosa, Alabama • Salem, Virginia

Conditions: Alzheimer Disease, Dementia, Mild Cognitive Impairment, Aging, Aging Disorder
Interventions: Not listed
Lead sponsor: Georgetown University; Other
Eligibility: 45 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Aging
Interventions: Western Diet, Non-Western Diet; Other
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 18 Years to 79 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Cognitive Decline
Interventions: Happy Older Latinos are Active (HOLA); Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Search by objective public record fields.

Radiation Therapy in Treating Patients With Prostate Cancer

N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)

Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain

Quantifying Myofascial Dysfunction in Post-Stroke Pain

Nebivolol Effects on Endothelial Function and Erectile Function

Guerbet Liver Fibrosis

The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)

Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia

Vietnamese Caregiver Intervention Study

Variability Analysis as a Predictor of Liberation From Mechanical Ventilation

Genetic Studies to Identify Stroke Subtypes and Outcome

Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia

Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI

Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease

Minds Navigating the Diagnosis of Mild Cognitive Impairment

DC Longitudinal Study on Aging and Specimen Bank

Age-associated Arterial Dysfunction, Western Diet, and Aerobic Exercise: Role of the Gut Microbiome

Happy Older Latinos Are Active - Cognitive Decline